- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03508362
Neurobiological Substrate of Social Context on Cognitive Control in Drug Users (STNdrugaddict)
The aim of the present project is to reveal, using Functional Magnetic Resonance Imaging (fMRI) in drug users, a specific modulation of brain structures and circuits involved in cognitive control (and especially those of inhibitory control) and reward while subjects are performing under the influence of drug-associated cues and in various social contexts.
This hypothesis, based on the animal work, is that the subthalamic nucleus (STN) should play a critical role in these processes. Addictive behaviour can be seen as a loss of control resulting from reduced inhibitory control, leading to compulsive drug use. These disorders are known to be associated with a hypoactivation of specific frontal regions such as the anterior cingulate cortex or the prefrontal cortex.
For the present experiment, it is chosen to use a procedure well established for neurophysiological and behavioural assessment of inhibitory processes : the " stop-signal reaction time task ".
This task requires to inhibit a motor response (press a button) at the onset of a stop signal (a tone) that occurs while the response is already engaged. In this task associated with fMRI, it was previously shown that the STN is involved in the control of inhibition. These results confirm our data in the rat, and especially those showing that STN lesions block the ability to stop. The stop signal task will thus be appropriate to study the effect of the social context on inhibitory processes in a population of cocaine users.
In cocaine abusers, it was shown that inhibitory processes are affected. Here we aim at testing this population of subjects while they perform the stop task, but adding an implicit cognitive load induced by visual cues associated or not with cocaine intake. Since it want to assess the influence of a peer on both the performance and the associated cerebral activities, it will also control the presence of a peer observer in the procedure.
There will thus be three experimental factors, one inter-subject factor (the experimental group, cocaine users or controls) and two intra-subject factors (cocaine associated or neutral cue; presence of a peer observer). The "stop-signal" task should induce increased activity of the STN that should be modulated by the cocaine-associated cues and by the presence of a peer.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Marseille, France, 13354
- Recruiting
- Assistance Publique Hopitaux de Marseille
-
Contact:
- Nicolas SIMON, PU-PH
- Phone Number: +33 491744051
- Email: nicolas.simon@ap-hm.fr
-
Contact:
- Christelle BAUNEZ, PhD, HDR
- Phone Number: +33 491324062
- Email: christelle.baunez@univ-amu.fr
-
Principal Investigator:
- Nicolas SIMON, PU-PH
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Drug Users Group
- age between 18 and 65 years
- regular use of cocaine and crack
- willing to participate
- able to give consent
- not meeting any non-inclusion criteria
- right-handed
Healthy volunteers group
- age between 18 and 65 years
- non-drug user
- willing to participate
- able to give consent
- not meeting any non-inclusion criteria
- right-handed
Exclusion Criteria:
- protected persons
- lactating women
- intolerance to noise
- not a beneficiary of a social security scheme.
- no signature on the consent form
- significant psychiatric or neurological disorder
- known visual impairment and abnormal vision despite correction
- Contraindication to MRI examination
- Claustrophobia.
- Pregnant women
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Drug user
Regular use of cocaine
|
Acquisition of a functional MRI on the sub thalamic nucleus
|
|
Active Comparator: Healthy volunteers
non-drug user
|
Acquisition of a functional MRI on the sub thalamic nucleus
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Functional MRI highlighting a specific modulation of the structures involved in the cognitive control circuit
Time Frame: 24 months
|
Compare in each group the regional brain activity through the measurement of cerebral oxygenation (blood oxygenation level dependent, BOLD).
Increased activity in the subthalamic nucleus (STN) in relation to drug use.
|
24 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2017-64
- 2017-A03395-48 (Registry Identifier: ID RCB)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Drug Use
-
Chestnut Health SystemsNational Institute on Drug Abuse (NIDA)Active, not recruitingPolysubstance Drug Use (Indiscriminate Drug Use)United States
-
University of California, Los AngelesInstituto Nacional de Psiquiatría Dr. Ramón de la FuenteCompletedDrug Use | Harmful Use
-
University of California, Los AngelesCompleted
-
University of California, Los AngelesNational Institute on Drug Abuse (NIDA); Medical University of South Carolina; University of ArkansasActive, not recruitingDrug UseUnited States
-
Hamad Medical CorporationPrimary Health Care Corporation, QatarActive, not recruiting
-
PT. Kimia Farma (Persero) TbkPT Pharma Metric LabsCompleted
-
PT BernofarmPT Pharma Metric LabsCompleted
-
Ain Shams UniversityRecruiting
-
PT Kalbe Farma TbkPT Pharma Metric LabsCompleted
-
University of California, Los AngelesNational Institutes of Health (NIH)Completed
Clinical Trials on Functional Magnetic Resonance Imaging (fRMI)
-
University Hospital, GrenobleCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedGlioma | Brain MassUnited States
-
University of Texas Southwestern Medical CenterWithdrawn
-
Stanford UniversityCompletedAnorexia Nervosa | Obsessive-compulsive DisorderUnited States
-
Children's Hospital Medical Center, CincinnatiCompleted
-
Barcelonabeta Brain Research Center, Pasqual Maragall...Completed
-
Oregon Research InstituteNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
University Hospital, ToulouseCompleted